Atezolizumab plus bevacizumab as first-line systemic therapy for hepatocellular carcinoma: a multi-institutional cohort study
Published in 2024 by
Amit Mahipal,
Michael H. Storandt,
Tyler J. Zemla,
Kanchi Patell,
Nikolas Naleid,
Jennifer J. Gile,
Nguyen H. Tran,
Sakti Chakrabarti,
Zhaohui Jin 
,
Mitesh Borad
,
Mitesh Borad
